2017 Q1 Form 10-Q Financial Statement

#000143774917008436 Filed on May 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $54.11M $46.64M
YoY Change 16.03% -13.78%
Cost Of Revenue $44.15M $33.16M
YoY Change 33.16% -13.45%
Gross Profit $6.130M $11.05M
YoY Change -44.54% -16.98%
Gross Profit Margin 11.33% 23.7%
Selling, General & Admin $1.900M $1.800M
YoY Change 5.56% 0.0%
% of Gross Profit 31.0% 16.29%
Research & Development $755.0K $687.0K
YoY Change 9.9% -3.92%
% of Gross Profit 12.32% 6.22%
Depreciation & Amortization $2.896M $2.622M
YoY Change 10.45% 13.95%
% of Gross Profit 47.24% 23.72%
Operating Expenses $2.655M $2.524M
YoY Change 5.19% -0.51%
Operating Profit $3.475M $8.529M
YoY Change -59.26% -20.86%
Interest Expense $43.00K $43.00K
YoY Change 0.0% 616.67%
% of Operating Profit 1.24% 0.5%
Other Income/Expense, Net $1.518M $168.0K
YoY Change 803.57% -92.49%
Pretax Income $4.993M $8.697M
YoY Change -42.59% -33.17%
Income Tax $1.597M -$1.872M
% Of Pretax Income 31.98% -21.52%
Net Earnings $3.396M $10.57M
YoY Change -67.87% 29.98%
Net Earnings / Revenue 6.28% 22.66%
Basic Earnings Per Share $0.08 $0.24
Diluted Earnings Per Share $0.08 $0.24
COMMON SHARES
Basic Shares Outstanding 43.62M 43.48M
Diluted Shares Outstanding 43.62M 43.49M

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $202.8M $220.7M
YoY Change -8.09% -9.11%
Cash & Equivalents $94.69M $148.3M
Short-Term Investments $108.1M $72.36M
Other Short-Term Assets $677.0K $1.868M
YoY Change -63.76% -43.39%
Inventory $51.88M $69.91M
Prepaid Expenses $1.543M $1.536M
Receivables $19.85M $54.47M
Other Receivables $17.10M $12.90M
Total Short-Term Assets $305.4M $367.7M
YoY Change -16.94% 9.13%
LONG-TERM ASSETS
Property, Plant & Equipment $116.0M $122.5M
YoY Change -5.26% -4.0%
Goodwill
YoY Change
Intangibles $1.408M $1.408M
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets $3.884M $3.205M
YoY Change 21.19% 6.83%
Total Long-Term Assets $121.6M $127.5M
YoY Change -4.63% -2.35%
TOTAL ASSETS
Total Short-Term Assets $305.4M $367.7M
Total Long-Term Assets $121.6M $127.5M
Total Assets $427.0M $495.2M
YoY Change -13.77% 5.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.38M $31.23M
YoY Change -44.34% -8.43%
Accrued Expenses $3.870M $4.412M
YoY Change -12.28% -43.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $37.97M $44.72M
YoY Change -15.11% -14.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.349M $1.234M
YoY Change 171.39% -93.83%
Total Long-Term Liabilities $50.47M $47.49M
YoY Change 6.27% 137.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.97M $44.72M
Total Long-Term Liabilities $50.47M $47.49M
Total Liabilities $88.44M $92.22M
YoY Change -4.1% -10.56%
SHAREHOLDERS EQUITY
Retained Earnings $51.58M $121.0M
YoY Change -57.36%
Common Stock $4.000K $4.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $338.6M $403.0M
YoY Change
Total Liabilities & Shareholders Equity $427.0M $495.2M
YoY Change -13.77% 5.93%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $3.396M $10.57M
YoY Change -67.87% 29.98%
Depreciation, Depletion And Amortization $2.896M $2.622M
YoY Change 10.45% 13.95%
Cash From Operating Activities $8.282M $1.197M
YoY Change 591.9% -97.09%
INVESTING ACTIVITIES
Capital Expenditures $898.0K $897.0K
YoY Change 0.11% -64.67%
Acquisitions
YoY Change
Other Investing Activities -$9.160M -$3.230M
YoY Change 183.59% -817.78%
Cash From Investing Activities -$10.06M -$4.122M
YoY Change 143.93% 97.04%
FINANCING ACTIVITIES
Cash Dividend Paid $102.8M $2.623M
YoY Change 3819.67% 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -102.8M -2.812M
YoY Change 3556.22% 6.31%
NET CHANGE
Cash From Operating Activities 8.282M 1.197M
Cash From Investing Activities -10.06M -4.122M
Cash From Financing Activities -102.8M -2.812M
Net Change In Cash -104.6M -5.737M
YoY Change 1723.01% -115.78%
FREE CASH FLOW
Cash From Operating Activities $8.282M $1.197M
Capital Expenditures $898.0K $897.0K
Free Cash Flow $7.384M $300.0K
YoY Change 2361.33% -99.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
CY2016Q4 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
142000
CY2017Q1 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
3870000
CY2016Q4 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
2485000
CY2017Q1 ff Blending Tax Credit
BlendingTaxCredit
0
CY2016Q4 ff Blending Tax Credit
BlendingTaxCredit
5495000
CY2017Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
-1202000
CY2016Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
-3398000
CY2017Q1 ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
2898000
CY2016Q1 ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
1521000
CY2017Q1 ff Distribution Related Parties
DistributionRelatedParties
40000
CY2016Q1 ff Distribution Related Parties
DistributionRelatedParties
106000
CY2017Q1 ff Excess Tax Benefit Expense From Sharebased Compensation Financing Activities
ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
CY2016Q1 ff Excess Tax Benefit Expense From Sharebased Compensation Financing Activities
ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
-136000
CY2017Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
-142000
CY2016Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
CY2017Q1 ff Increase Decrease Prepaid Expenses Related Parties
IncreaseDecreasePrepaidExpensesRelatedParties
11000
CY2016Q1 ff Increase Decrease Prepaid Expenses Related Parties
IncreaseDecreasePrepaidExpensesRelatedParties
CY2017Q1 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
23000
CY2016Q4 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000
CY2017Q1 ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
53648000
CY2016Q1 ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
43204000
CY2017Q1 ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
10000
CY2016Q1 ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
44000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
17381000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22799000
CY2017Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1625000
CY2016Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1254000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19848000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24359000
CY2017Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
2636000
CY2016Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
385000
CY2017Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1605000
CY2016Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1428000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3870000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2627000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5415000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3540000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2055000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2495000
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281564000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281087000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36000
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36000
CY2017Q1 us-gaap Assets
Assets
426997000
CY2016Q4 us-gaap Assets
Assets
529043000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
305369000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
405282000
CY2017Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
121628000
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
123761000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0
CY2017Q1 us-gaap Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
-131000
CY2016Q1 us-gaap Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
-1018000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94686000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199272000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154049000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148312000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-104586000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5737000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43749970
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43749970
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43749970
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43749970
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
4000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5271000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11009000
CY2017Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
144000
CY2016Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
144000
CY2017Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
289000
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
325000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1761000
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3822000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6063000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5530000
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
15808000
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
44154000
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
33158000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
16792000
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
31314000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
32064000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2896000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2622000
CY2017Q1 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-1460000
CY2016Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-258000
CY2017Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1279000
CY2016Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1039000
CY2017Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width: 56px; vertical-align: top;"> <div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">)</div></div></div> </td> <td style="width: 1689px; vertical-align: top;"> <div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">RECENTLY ISSUED ACCOUNTING STATEMENTS</div></div></div> </td> </tr> </table> <div style=" margin: 0pt 7.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr> <td colspan="7" style="width: 100%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following table provides a brief description of recent Accounting Standard Updates (&quot;ASU&quot;) issued by the FASB:</div> </td> </tr> <tr> <td style="width: 23.8%; vertical-align: bottom;">&nbsp;</td> <td style="width: 2.4%; vertical-align: bottom;">&nbsp;</td> <td style="width: 28.6%; vertical-align: bottom;">&nbsp;</td> <td style="width: 2.4%; vertical-align: bottom;">&nbsp;</td> <td style="width: 18%; vertical-align: bottom;">&nbsp;</td> <td style="width: 2.4%; vertical-align: bottom;">&nbsp;</td> <td style="width: 22.5%; vertical-align: bottom;">&nbsp;</td> </tr> <tr> <td style="width: 23.8%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Standard</div></div> </td> <td style="width: 2.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;">&nbsp;</td> <td style="width: 28.6%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Description</div></div> </td> <td style="width: 2.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;">&nbsp;</td> <td style="width: 18%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Effective Date</div></div> </td> <td style="width: 2.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;">&nbsp;</td> <td style="width: 22.5%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Effect on the Financial Statements or Other Significant Matters</div></div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 23.8%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Leases.</div> </td> <td style="width: 2.4%; vertical-align: top;">&nbsp;</td> <td style="width: 28.6%; vertical-align: top; border-left-color: rgb(0, 0, 0); border-left-width: thin; border-left-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The new guidance supersedes the lease guidance under FASB&nbsp;ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840,</div> Leases, resulting in the creation of FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842,</div> Leases. The guidance requires a lessee to recognize in the statement of financial position a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term for both finance and operating leases.</div> </td> <td style="width: 2.4%; vertical-align: top;">&nbsp;</td> <td style="width: 18%; vertical-align: top; border-left-color: rgb(0, 0, 0); border-left-width: thin; border-left-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> Early adoption is permitted.</div> </td> <td style="width: 2.4%; vertical-align: top;">&nbsp;</td> <td style="width: 22.5%; vertical-align: top; border-left-color: rgb(0, 0, 0); border-left-width: thin; border-left-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company is currently evaluating its population of leases, and is continuing to assess all potential impacts of the standard, but currently believes the most significant impact relates to its accounting for logistics equipment. The Company anticipates recognition of additional assets and corresponding liabilities related to leases upon adoption. The Company plans to adopt the standard effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div></div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="width: 23.8%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Revenue from Contracts with Customers. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div></div> </td> <td style="width: 2.4%; vertical-align: top;">&nbsp;</td> <td style="width: 28.6%; vertical-align: top; border-left-color: rgb(0, 0, 0); border-left-width: thin; border-left-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The core principle of this guidance is that an<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. To achieve the core principle, the guidance establishes the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps: <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1)</div> identify the contract(s) with a customer, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2)</div> identify the performance obligation in the contract, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3)</div> determine the transaction price, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4)</div> allocate the transaction price to the performance obligations in the contract, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5)</div> recognize revenue when (or as) the entity satisfies a performance obligation. The guidance also details the accounting treatment for costs to obtain or fulfill a contract. Lastly, disclosure requirements have been enhanced to provide sufficient information to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.</div></div> </td> <td style="width: 2.4%; vertical-align: top;">&nbsp;</td> <td style="width: 18%; vertical-align: top; border-left-color: rgb(0, 0, 0); border-left-width: thin; border-left-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">Earlier adoption was permitted, but not before <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> </td> <td style="width: 2.4%; vertical-align: top;">&nbsp;</td> <td style="width: 22.5%; vertical-align: top; border-left-color: rgb(0, 0, 0); border-left-width: thin; border-left-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company is in the process of evaluating the impact of this guidance.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;This new guidance,&nbsp;will likely&nbsp;result in a change in the nature and extent of the related footnote disclosures. The Company plans to adopt the new guidance when effective and presently anticipates adopting on a modified retrospective basis to each prior reporting period presented with the election of applicable practical expedients.</div></div> </td> </tr> </table></div>
CY2017Q1 us-gaap Distributed Earnings
DistributedEarnings
CY2016Q1 us-gaap Distributed Earnings
DistributedEarnings
15000
CY2017Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
7875000
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
110688000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.32
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.215
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2015000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
864000
CY2017Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
46000
CY2016Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
222000
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-31000
CY2016Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-115000
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-106000
CY2017Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
1223000
CY2016Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
1349000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6207
CY2017Q1 us-gaap Gross Profit
GrossProfit
6130000
CY2016Q1 us-gaap Gross Profit
GrossProfit
11053000
CY2017Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
177000
CY2016Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
1240000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4993000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8697000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1597000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1872000
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
906000
CY2017Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
17102000
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
20508000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5418000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3217000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
371000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
49000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4511000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8153000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
2251000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
2293000
CY2017Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-13000
CY2016Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
30000
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1385000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1436000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-451000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2720000
CY2017Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3406000
CY2016Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1228000
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-218000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4950000
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
94000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
8000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
127000
CY2017Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-151000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
10918
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2017Q1 us-gaap Interest Expense
InterestExpense
43000
CY2017Q1 us-gaap Inventory Adjustments
InventoryAdjustments
955000
CY2016Q1 us-gaap Inventory Adjustments
InventoryAdjustments
3544000
CY2016Q1 us-gaap Interest Expense
InterestExpense
43000
CY2017Q1 us-gaap Interest Expense Other
InterestExpenseOther
6000
CY2016Q1 us-gaap Interest Expense Other
InterestExpenseOther
7000
CY2017Q1 us-gaap Interest Paid
InterestPaid
CY2016Q1 us-gaap Interest Paid
InterestPaid
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29183000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27971000
CY2017Q1 us-gaap Inventory Gross
InventoryGross
56670000
CY2016Q4 us-gaap Inventory Gross
InventoryGross
55011000
CY2017Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
4795000
CY2016Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2918000
CY2017Q1 us-gaap Inventory Net
InventoryNet
51875000
CY2016Q4 us-gaap Inventory Net
InventoryNet
52093000
CY2017Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
25559000
CY2016Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
25127000
CY2017Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1928000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1913000
CY2017Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1723000
CY2016Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1345000
CY2017Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1723
CY2016Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1345
CY2017Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
15511000
CY2016Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
31126000
CY2017Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1264000
CY2016Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1166000
CY2017Q1 us-gaap Liabilities
Liabilities
88436000
CY2016Q4 us-gaap Liabilities
Liabilities
196230000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
426997000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529043000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
37965000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144049000
CY2017Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
50471000
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
52181000
CY2017Q1 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
1151000
CY2016Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
1151000
CY2017Q1 us-gaap Marketable Securities
MarketableSecurities
108142000
CY2016Q4 us-gaap Marketable Securities
MarketableSecurities
100339000
CY2017Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
116835000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
106146000
CY2017Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-131000
CY2016Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-1018000
CY2017Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width: 55px; vertical-align: top;"><div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">)</div></div></div> </td> <td style="width: 1690px; vertical-align: top;"> <div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NATURE OF OPERATIONS AND BASIS OF PRESENTATION</div></div> </td> </tr> </table> <div style=" margin: 0pt 7.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Organization</div></div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">FutureFuel Corp. (&#x201c;FutureFuel&#x201d;), through its wholly-owned subsidiary, FutureFuel Chemical Company (&#x201c;FutureFuel Chemical&#x201d;), owns and operates a chemical production facility located on approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,200</div> acres of land <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> miles southeast of Batesville in north central Arkansas fronting the White River (the &#x201c;Batesville Plant&#x201d;). FutureFuel Chemical manufactures diversified chemical products, biobased products comprised of biofuels, and biobased specialty chemical products. FutureFuel Chemical<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s operations are reported in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> segments: chemicals and biofuels.</div></div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The chemicals segment manufactures a diversified <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">portfolio of chemical products that are sold to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party customers. The majority of the revenues from the chemicals segment are derived from the custom manufacturing of specialty chemicals for specific customers.</div></div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The biofuels business segment primarily produces and sells biodiesel. FutureFuel Chemical also sells petrodiesel in blends with the company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s biodiesel and, from time to time, with no biodiesel added. Finally, FutureFuel Chemical is a shipper of refined petroleum products on common carrier pipelines and buys and sells petroleum products to maintain an active shipper status on these pipelines.</div></div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Basis</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style="display: inline; font-style: italic;">of</div> <div style="display: inline; font-style: italic;">Presentation</div></div></div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying unaudited consolidated financial statements have been prepared by FutureFuel in accordance and consistent with the accounting policies stated in FutureFuel<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> audited consolidated financial statements and should be read in conjunction with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> audited consolidated financial statements of FutureFuel.</div></div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt 0pt 43.5pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">In the opinion of FutureFuel, all normal recurring adjustments necessary for a fair presentation have been included in the unaudited consolidated financial statements. The unaudited consolidated financial statements have been prepared in compliance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information and with instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q adopted by the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, the financial statements do not include all the information and footnotes required by GAAP for complete financial statements, and do include amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The unaudited consolidated financial statements include assets, liabilities, revenues, and expenses of FutureFuel and its wholly owned subsidiaries; namely, FutureFuel Chemical Company, FFC Grain, L.L.C., FutureFuel Warehouse Company, L.L.C., and Legacy Regional Transport, L.L.C. Intercompany transactions and balances have been eliminated in consolidation.</div></div>
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-102813000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2812000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10055000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4122000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8282000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1197000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
3396000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
10569000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1518000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
168000
CY2017Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
2655000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
2524000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3475000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8529000
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
250000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
335000
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
677000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
669000
CY2017Q1 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
116835000
CY2016Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
106146000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3884000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3876000
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-131000
CY2016Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-1018000
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-85000
CY2016Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-661000
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-46000
CY2016Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-357000
CY2017Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
1790000
CY2016Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-221000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1875000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
440000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2886000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3349000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
678000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1875000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
440000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1011000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
238000
CY2017Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
580000
CY2016Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
623000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3325000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-116000
CY2017Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-205000
CY2016Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1177000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31000
CY2017Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
3386000
CY2016Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
10510000
CY2017Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3386000
CY2016Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
10510000
CY2017Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
102813000
CY2016Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2623000
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
CY2016Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
53000
CY2015Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1408000
CY2017Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15818000
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11000000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
898000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
897000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1543000
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1694000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7884000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9124000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116047000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118152000
CY2017Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-85000
CY2016Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-661000
CY2017Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
56000
CY2016Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
48000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
755000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
687000
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1982000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
758000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
51578000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48182000
CY2017Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
463000
CY2016Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
3431000
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
54111000
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
46635000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
477000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
477000
CY2017Q1 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
889000
CY2016Q1 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
797000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
338561000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
332813000
CY2017Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10000
CY2016Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
44000
CY2017Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
10000
CY2016Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
44000
CY2017Q1 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
9089000
CY2016 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
6844000
CY2017Q1 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
396000
CY2016 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
1037000
CY2017Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2056000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2056000
CY2017Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
211000
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
193000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43622843
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43486548
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43616636
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43475630

Files In Submission

Name View Source Status
0001437749-17-008436-index-headers.html Edgar Link pending
0001437749-17-008436-index.html Edgar Link pending
0001437749-17-008436.txt Edgar Link pending
0001437749-17-008436-xbrl.zip Edgar Link pending
ex11.htm Edgar Link pending
ex31-a.htm Edgar Link pending
ex31-b.htm Edgar Link pending
ex32.htm Edgar Link pending
ff-20170331.xml Edgar Link completed
ff-20170331.xsd Edgar Link pending
ff-20170331_cal.xml Edgar Link unprocessable
ff-20170331_def.xml Edgar Link unprocessable
ff-20170331_lab.xml Edgar Link unprocessable
ff-20170331_pre.xml Edgar Link unprocessable
ff20170331_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
futurefuelcorplogo-300dpi.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending